Analyst Rating Update on Stryker Corporation (SYK)

Stryker Corporation (SYK) : The consensus on Stryker Corporation (SYK) based on 24 analyst recommendation on the company stock is 1.9, which is interpreted as a Buy recommendation. Zacks Investment Research has issued a rank of 3 which endorses a Hold on the stock. However, 14 brokers have a differing view as they consider the stock to be a Strong Buy at current levels. 2 analyst believes that the stock is a Buy, which can produce decent returns in the future. 6 experts consider that the stocks earnings and the quoted price is in harmony, hence, they give it a Hold rating. 2 analyst sees the stock overvalued at current levels and advises a Strong Sell on the stock.

Stryker Corporation (SYK) : The most positive equity analysts on Stryker Corporation (SYK) expects the shares to touch $138, whereas, the least positive believes that the stock will trade at $88 in the short term. The company is covered by 18 Wall Street Brokerage Firms. The average price target for shares are $124.78 with an expected fluctuation of $11.62 from the mean.

For the current week, the company shares have a recommendation consensus of Buy.


Stryker Corporation (NYSE:SYK): The stock opened at $115.88 on Wednesday but the bulls could not build on the opening and the stock topped out at $115.97 for the day. The stock traded down to $114.54 during the day, due to lack of any buying support eventually closed down at $114.82 with a loss of -0.76% for the day. The stock had closed at $115.70 on the previous day. The total traded volume was 1,080,183 shares.

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine, which help improve patient and hospital outcomes.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *